Actualités Statera BioPharma Inc - STAB | Actions NASDAQ

Votre Hub pour des idées et discussions en direct en temps réel

Statera Biopharma Signs Letter of Intent for Merger with Worksite Labs

FORT COLLINS, Colo., March 15, 2023 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (OTCPK:STAB) (the "Company...

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER...

Proxy Statement (definitive) (def 14a)

TABLE OF CONTENTS UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, DC 20549 SCHEDULE 14A(Rule 14a-101)Proxy Statement Pursuant to...

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

TABLE OF CONTENTS UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, DC 20549 SCHEDULE 14A(Rule 14a-101)Proxy Statement Pursuant to...

Current Report Filing (8-k)

false 0001318641 0001318641 2023-01-26 2023-01-26 --12-31 UNITED STATES SECURITIES...

Securities Registration (section 12(g)) (8-a12g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A ...

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

TABLE OF CONTENTS UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, DC 20549 SCHEDULE 14A(Rule 14a-101)Proxy Statement Pursuant to...

Current Report Filing (8-k)

false 0001318641 0001318641 2022-11-07 2022-11-07 UNITED STATES SECURITIES AND...

Quarterly Report (10-q)

0001318641 Statera Biopharma, Inc (fka Cytocom Inc) false --12-31 Q3 2022 0.005 0.005 1,000,000 1,000,000 0 0 0 0 0.005 0.005 150...

Current Report Filing (8-k)

false 0001318641 0001318641 2022-10-26 2022-10-26 UNITED STATES SECURITIES AND...

Quarterly Report (10-q)

0001318641 Statera Biopharma, Inc (fka Cytocom Inc) false --12-31 Q1 2022 0.005 0.005 0.005 0.005 1,000,000 1,000,000 0 0 0 0 0.0...

Current Report Filing (8-k)

false 0001318641 0001318641 2022-10-11 2022-10-11 UNITED STATES SECURITIES AND...

Annual Report (10-k)

0001318641 Statera Biopharma, Inc (fka Cytocom Inc) false --12-31 FY 2021 0.005 0.005 1,000,000 1,000,000 0 0 0 0 0.005 0.005 150...

Amended Current Report Filing (8-k/a)

Form 8-K/A date of report 06-13-22 true 0001318641 0001318641 2022-06-13 2022-06-13 UNITE...

Current Report Filing (8-k)

false 0001318641 0001318641 2022-09-01 2022-09-01 UNITED STATES SECURITIES AND...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Statera BioPharma Inc (STAB)

Votre Hub pour des idées et discussions en direct en temps réel

STAB Actualités

Statera Biopharma Signs Letter of Intent for Merger with Worksite Labs

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)

Proxy Statement (definitive) (def 14a)

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

Current Report Filing (8-k)

Securities Registration (section 12(g)) (8-a12g)

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

Current Report Filing (8-k)

Quarterly Report (10-q)

Current Report Filing (8-k)

Quarterly Report (10-q)

Current Report Filing (8-k)

Annual Report (10-k)

Amended Current Report Filing (8-k/a)

Current Report Filing (8-k)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Statera BioPharma Inc (STAB) Actualités

Statera BioPharma Inc (STAB)

Votre Hub pour des idées et discussions en direct en temps réel

STAB Actualités

Statera Biopharma Signs Letter of Intent for Merger with Worksite Labs

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)

Proxy Statement (definitive) (def 14a)

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

Current Report Filing (8-k)

Securities Registration (section 12(g)) (8-a12g)

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

Current Report Filing (8-k)

Quarterly Report (10-q)

Current Report Filing (8-k)

Quarterly Report (10-q)

Current Report Filing (8-k)

Annual Report (10-k)

Amended Current Report Filing (8-k/a)

Current Report Filing (8-k)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application